ITM-31

N/A

Report date: 2025/09/22 17:57:06

Base Information

Drug NameITM-31
Drug Alias NameLuCaFabLu-177 Labeled 6A10 Fab-fragmentsITM-31177Lu-ITM-31
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Lutetium > 177Lu +[5] 
Mechanisms of ActionAnti-Carbonic anhydrase XIIIonising radiation emitters
TargetsCarbonic anhydrase XII
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Center Munich
China Registration ClassN/A

Develop Information

Active CompaniesHelmholtz Center MunichHelmholtz Zentrum MunchenITM Isotope Technologies Munich SE
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A